New pill aims to shed pounds without diabetes

NCT ID NCT07658560

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 2 trial tests whether BGM0504 tablets can help overweight or obese adults without diabetes lose weight. About 200 Chinese participants will take either the drug or a placebo daily for 20 weeks. Researchers will measure changes in body weight, waist size, and blood sugar levels, while also monitoring safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

BGM0504 tablets

What this could lead to

If successful, this could lead to a new weight-loss medication for people who are overweight or obese but do not have diabetes.

What could go wrong

This is an early Phase 2 trial with only 200 participants, so results may not apply to everyone. Side effects are possible, and the drug may not prove more effective than placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Peking University People's Hospital

    Beijing, Beijing Municipality, 100044, China